SPON1 that encodes a secreted extracellular matrix glycoprotein is one of the DEGs in metastatic or poorly differentiated gastric cancer, being associated with tumor aggressiveness and poor prognosis of patients (Ding Y. et al., 2020). Here, SPON1 is linked to gastric cancer.